Titration

Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Report 2021-2025: Market is Poised to Grow by $265.55 Million - Increase in Chronic Diseases Driving Market Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 28, 2021
Other Science, Science, Chemistry, Physical sciences, Laboratory techniques, Assay, Biochemistry, Titration, ELISA, ELISA, Branches of biology, Immunology, Enzyme immunoassay, Chlamydia antibodies

The "Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • The report on the enzyme-linked immunosorbent assay (Elisa) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The enzyme-linked immunosorbent assay (Elisa) testing market analysis includes the end-user segment and geographic landscape.
  • This study identifies the increase in chronic diseases as one of the prime reasons driving the enzyme-linked immunosorbent assay (Elisa) testing market growth during the next few years.

Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay

Retrieved on: 
Wednesday, July 28, 2021
Natural sciences, Chemistry, Physical sciences, Laboratory techniques, Immunologic tests, Titration, Immunology, Biochemistry methods, Multiplex, Assay, Titer, Immunoassay

Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on Ella instruments, its multiplexing immunoassay system.

Key Points: 
  • Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on Ella instruments, its multiplexing immunoassay system.
  • Featuring antibodies from PROGEN, the Simple Plex AAV2 viral titer assay detects assembled viral capsids as well as the comprehensively characterized AAV2 standard to deliver industry leading specificity.
  • Available on the Ella platform, the Simple Plex AAV2 assay utilizes the recombinant AAV2 antibody (A20R) from industry leader PROGEN to quantify assembled AAV2 capsids.
  • "Working with ProteinSimple to develop the Simple Plex AAV2 assay was a great experience," said Katja Betts, CEO of PROGEN.

Two Day Online Seminar for Designing and Sustaining New and Existing Pharma/Biotech Product Stability Testing Program (October 6-7, 2021) - ResearchAndMarkets.com

Retrieved on: 
Monday, July 26, 2021
Training, Education, Software testing, Academic disciplines, Science, Assay, Biochemistry, Titration, Sampling, Methodology

Performing an effective sampling plan and utilizing the appropriate sample size for a stability testing program.

Key Points: 
  • Performing an effective sampling plan and utilizing the appropriate sample size for a stability testing program.
  • Performing a compliant sample analysis, handling and effecting the appropriate test specification for the product type.
  • How to Effectively Handle, Manage Data, Utilize and Perform the Trending of Stability Testing Results and Data.
  • Knowledge Base: Attendees will gain an understanding in the following key areas:
    How to perform Quality Control Testing, Setting Test Specification and Assay Release Process in a Stability Testing Program.

Galleon Gold Extends Gold Mineralization on Eastern Flank at West Cache Project

Retrieved on: 
Wednesday, July 21, 2021
Assay, Biochemistry, Titration

Toronto, Ontario--(Newsfile Corp. - July 21, 2021) - Galleon Gold Corp. (TSXV: GGO) (the "Company" or "Galleon Gold") is pleased to announce final assay results from the 2021 East Pit extension drill program at the Company's 100% owned West Cache Gold Project, Timmins, Ontario.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - July 21, 2021) - Galleon Gold Corp. (TSXV: GGO) (the "Company" or "Galleon Gold") is pleased to announce final assay results from the 2021 East Pit extension drill program at the Company's 100% owned West Cache Gold Project, Timmins, Ontario.
  • With all assays now complete for this area, results continue to confirm the easterly extension of multiple gold zones.
  • This was the second set of holes targeting the eastern margins of our known mineralization, and results confirm the trend is open-ended and our pit and underground potential continues to grow.
  • Close-up photos of the East Extension mineralization with corresponding gold grades can be seen in Figure 5.

Vyant Bio Announces Issuance of Key Patent for High-Throughput Optical Assay of Human Mixed Cell Population Spheroids

Retrieved on: 
Tuesday, July 13, 2021
Life sciences, Natural sciences, Intellectual property law, Biotechnology, Stem cells, Assay, Biochemistry, Titration, United States Patent and Trademark Office, Patent, Drug discovery, Induced pluripotent stem cell

11054408, titled High Throughput Optical Assay of Human Mixed Cell Population Spheroids by the United States Patent and Trademark Office (USPTO).

Key Points: 
  • 11054408, titled High Throughput Optical Assay of Human Mixed Cell Population Spheroids by the United States Patent and Trademark Office (USPTO).
  • The issuance of the 11054408 patent is the third patent granted to StemoniX: additional applications are currently pending worldwide.
  • Human iPSCs offer many advantages over recombinant cell lines or primary rodent cells for use in drug screening.
  • Vyant Bio, Inc. (Vyant Bio, the Company) (Nasdaq: VYNT) is emerging as an advanced biotechnology drug discovery company.

Nephros Announces Acquisition of GenArraytion, Inc.

Retrieved on: 
Monday, July 12, 2021
Natural sciences, Laboratory techniques, Chemistry, Physical sciences, Molecular biology, Biotechnology, Amplifiers, Assay, Titration, Polymerase chain reaction

This acquisition will give Nephros access to GenArraytions many proprietary assays, multiplexing technology, and selection methods for detecting waterborne pathogens and other microorganisms using Polymerase Chain Reaction (PCR) technology.

Key Points: 
  • This acquisition will give Nephros access to GenArraytions many proprietary assays, multiplexing technology, and selection methods for detecting waterborne pathogens and other microorganisms using Polymerase Chain Reaction (PCR) technology.
  • GenArraytions assets will be integrated into the Nephros Pathogen Detection Systems platform.
  • I am very much looking forward to partnering with the Nephros team and realizing our shared vision around water safety."
  • Nephros is a leading water technology company in medical and commercial water purification and pathogen detection, headquartered in the USA.

Spanish Mountain Gold Reports Assay Results from Resource Expansion Program: Multiple Long Intercepts in All Four Tested Areas

Retrieved on: 
Tuesday, July 6, 2021
Chemistry, Physical sciences, Natural sciences, Laboratory techniques, Gold, Silver, Assay, Biochemistry, Titration, Quality assurance, BRITISH COLUMBIA, Quality control

Vancouver, British Columbia--(Newsfile Corp. - July 6, 2021) - Spanish Mountain Gold Ltd. (TSXV: SPA) (the "Company") is pleased to announce the assay results from the latest resource expansion program for the Spanish Mountain Gold Project (the "Project") located in British Columbia, Canada.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - July 6, 2021) - Spanish Mountain Gold Ltd. (TSXV: SPA) (the "Company") is pleased to announce the assay results from the latest resource expansion program for the Spanish Mountain Gold Project (the "Project") located in British Columbia, Canada.
  • Notably, the assay results report long intercepts (up to 68.58 m in length) in all four tested areas with grades higher than the economic cut-off established in the latest resource estimate (published along with the PFS).
  • The Company has retained Discovery Consultants of Vernon, BC, to monitor independently the quality control and quality assurance (QC/QA) data on the Spanish Mountain Gold Project.
  • Spanish Mountain Gold Ltd. is focused on advancing its 100%-owned Spanish Mountain gold project in southern central British Columbia.

Axiom Presents "Unified Platforms: How to Address the Complexity of Oncology Studies to Better Support Your Sites" at Clinical Operations in Oncology Trials 2021

Retrieved on: 
Thursday, June 24, 2021
Clinical data management, Clinical research, Clinical trial management system, Oncology, Titration, Natural sciences, Academic disciplines

They will share their expertise and highlight site-level operational needs of oncology studies, as well as how a unified platform can promote study accuracy, visibility and task automation.

Key Points: 
  • They will share their expertise and highlight site-level operational needs of oncology studies, as well as how a unified platform can promote study accuracy, visibility and task automation.
  • Key elements that bring complexity to oncology studies include enrollment and eligibility, patient scheduling and dose titration, as well as SRC readiness, Zarubick remarks.
  • A unified platform such as Axioms Fusion eClinical Suite can also serve as the connected hub for your oncology trial, DiFruscia contributes.
  • Since 2001, Axiom has delivered data-driven, powerful and cost-effective eClinical Solutions and Services dedicated to small-to-medium life science companies.

Amalgam Rx™ Receives CE Mark for Basal Insulin Titration

Retrieved on: 
Wednesday, June 16, 2021
Technology, Biotechnology, Mobile, Wireless, Diabetes, Health, Practice Management, Medical devices, Software, General Health, Hardware, Fitness & Nutrition, Data management, Consumer electronics, Medical Supplies, Branches of biology, Clinical medicine, Endocrine system, Diabetes, Peptide hormones, Recombinant proteins, Insulin, Basal, Titration, Glucose meter

Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, is announcing it has achieved the Conformit Europenne (CE) Mark for its insulin titration application, iSage Rx and its white-labeled variants.

Key Points: 
  • Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, is announcing it has achieved the Conformit Europenne (CE) Mark for its insulin titration application, iSage Rx and its white-labeled variants.
  • View the full release here: https://www.businesswire.com/news/home/20210616005524/en/
    Amalgam Rx Receives CE Mark for Basal Insulin Titration (Graphic: Business Wire)
    With this CE Mark, iSage Rxs capacity to support the titration of all basal insulins and enable connectivity to the leading Bluetooth-enabled blood glucose meters from Roche, Lifescan, and Ascensia, is now cleared for the European market.
  • In early clinical studies, the iSage Rx app has demonstrated the ability to improve patients glucose levels by helping them reach the appropriate level of basal insulin.
  • Amalgam is the manufacturer of the iSage Rx app and white-labeled variants, the first prescription-only mobile application for the automated titration of all brands of basal insulin to receive market authorization in the United States, EU, and Brazil.

Sanatana Gold Rush Project - Initial Assay Results Return 2m @ 2.22g/t Au

Retrieved on: 
Wednesday, June 16, 2021
Chemistry, Physical sciences, Natural sciences, Laboratory techniques, Assay, Biochemistry, Titration, Metallurgical assay, Drill

Buddy Doyle, President said, "The scout drilling program was initiated to gain a rapid understanding of the type and styles of mineralization on the Gold Rush property.

Key Points: 
  • Buddy Doyle, President said, "The scout drilling program was initiated to gain a rapid understanding of the type and styles of mineralization on the Gold Rush property.
  • The assay results will determine which prospects to focus further work on.
  • Additionally the results will help us to understand what are the main controls of the mineralization at the Gold Rush Project.
  • Assays have been returned for the North Vein prospect and we report a 2.22g/t Au interval in Drill hole NV-2021-03, 2m from 51m to 53m.